Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,623 | 198 | 99.5% |
| Education | $13.35 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $424.58 | 36 | $0 (2020) |
| ABBVIE INC. | $357.88 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $344.77 | 25 | $0 (2024) |
| Lilly USA, LLC | $309.01 | 24 | $0 (2024) |
| Novo Nordisk Inc | $189.66 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $178.75 | 13 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $160.09 | 17 | $0 (2019) |
| Allergan Inc. | $143.84 | 10 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $103.72 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $71.34 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $186.08 | 11 | Lilly USA, LLC ($49.03) |
| 2021 | $11.75 | 1 | AbbVie Inc. ($11.75) |
| 2020 | $128.24 | 9 | PFIZER INC. ($39.46) |
| 2019 | $754.29 | 57 | PFIZER INC. ($204.80) |
| 2018 | $622.39 | 49 | PFIZER INC. ($141.01) |
| 2017 | $933.56 | 73 | AbbVie, Inc. ($147.88) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Oncology | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Neuroscience | ||||||
| 03/11/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: RESPIRATORY | ||||||
| 03/04/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/21/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Cardiovascular | ||||||
| 01/31/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Endocrinology | ||||||
| 12/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 499 | 1,187 | $151,715 | $78,377 |
| 2022 | 17 | 670 | 1,531 | $206,391 | $109,653 |
| 2021 | 15 | 607 | 1,515 | $187,323 | $109,332 |
| 2020 | 13 | 570 | 1,502 | $171,099 | $93,363 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 70 | 308 | $30,800 | $18,757 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 219 | $38,325 | $16,725 | 43.6% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 33 | 165 | $17,985 | $9,210 | 51.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 90 | $15,480 | $8,925 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 122 | $17,080 | $6,955 | 40.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 71 | 95 | $9,975 | $5,877 | 58.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $8,800 | $5,391 | 61.3% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 32 | 67 | $10,720 | $5,267 | 49.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $870.00 | $851.44 | 97.9% |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | Office | 2023 | 30 | 30 | $1,500 | $406.90 | 27.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 18 | $180.00 | $12.82 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 270 | $47,250 | $22,298 | 47.2% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 36 | 204 | $34,068 | $19,836 | 58.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 293 | $29,300 | $15,959 | 54.5% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 23 | 173 | $27,680 | $15,727 | 56.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 74 | $12,728 | $7,762 | 61.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 129 | $18,060 | $7,115 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $9,775 | $6,290 | 64.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 68 | 75 | $7,875 | $4,081 | 51.8% |
| 99327 | New patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 18 | 18 | $4,626 | $2,555 | 55.2% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 15 | 33 | $3,927 | $2,218 | 56.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $1,740 | $1,560 | 89.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $2,700 | $1,464 | 54.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 23 | 43 | $2,451 | $1,161 | 47.4% |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | Office | 2022 | 57 | 57 | $1,311 | $782.26 | 59.7% |
About Dr. Vyacheslav Isakov, M.D
Dr. Vyacheslav Isakov, M.D is a Family Medicine healthcare provider based in Wickliffe, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407826803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vyacheslav Isakov, M.D has received a total of $2,636 in payments from pharmaceutical and medical device companies, with $186.08 received in 2024. These payments were reported across 200 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,623).
As a Medicare-enrolled provider, Isakov has provided services to 2,346 Medicare beneficiaries, totaling 5,735 services with total Medicare billing of $390,725. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wickliffe, OH
- Active Since 01/26/2006
- Last Updated 12/14/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407826803
Products in Payments
- Creon (Drug) $325.38
- FARXIGA (Drug) $306.94
- CHANTIX (Drug) $269.40
- XARELTO (Drug) $135.64
- ELIQUIS (Drug) $123.93
- TRULICITY (Drug) $122.78
- JANUVIA (Drug) $117.39
- LINZESS (Drug) $93.06
- ANORO (Drug) $71.34
- Tresiba (Drug) $67.39
- Victoza (Drug) $63.74
- LYRICA (Drug) $57.45
- BASAGLAR (Drug) $49.58
- MOUNJARO (Drug) $49.03
- Livalo (Drug) $44.93
- INVOKANA (Drug) $43.11
- Ozempic (Drug) $40.25
- XIFAXAN (Drug) $40.16
- VIAGRA (Drug) $39.31
- TRADJENTA (Drug) $37.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.